Fulgent Genetics Inc. (NASDAQ:FLGT) went down by -20.75% from its latest closing price compared to the recent 1-year high of $189.89. The company’s stock price has collected -34.56% of loss in the last five trading sessions. Press Release reported on 02/18/21 that Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021
Is It Worth Investing in Fulgent Genetics Inc. (NASDAQ :FLGT) Right Now?
Fulgent Genetics Inc. (NASDAQ:FLGT) scored a price-to-earnings ratio above its average ratio, recording 52.16 x from its present earnings ratio. Plus, the 36-month beta value for FLGT is at 1.73. Opinions of the stock are interesting as 2 analysts out of 4 who provided ratings for Fulgent Genetics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 1 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $101.67, which is -$20.42 below the current price. FLGT currently public float of 14.29M and currently shorts hold a 29.22% ratio of that float. Today, the average trading volume of FLGT was 2.13M shares.
FLGT’s Market Performance
FLGT stocks went down by -34.56% for the week, with a monthly jump of 59.17% and a quarterly performance of 142.79%, while its annual performance rate touched 454.84%. The volatility ratio for the week stands at 15.37% while the volatility levels for the past 30 days are set at 16.50% for Fulgent Genetics Inc.. The simple moving average for the period of the last 20 days is -17.44% for FLGT stocks with a simple moving average of 141.03% for the last 200 days.
Analysts’ Opinion of FLGT
Many brokerage firms have already submitted their reports for FLGT stocks, with Credit Suisse repeating the rating for FLGT by listing it as a “Underperform.” The predicted price for FLGT in the upcoming period, according to Credit Suisse is $40 based on the research report published on January 08th of the current year 2021.
Oppenheimer gave a rating of “Outperform” to FLGT, setting the target price at $75 in the report published on August 20th of the previous year.
FLGT Trading at 24.22% from the 50-Day Moving Average
After a stumble in the market that brought FLGT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.48% of loss for the given period.
Volatility was left at 16.50%, however, over the last 30 days, the volatility rate increased by 15.37%, as shares surge +52.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +117.05% upper at present.
During the last 5 trading sessions, FLGT fell by -34.56%, which changed the moving average for the period of 200-days by +623.54% in comparison to the 20-day moving average, which settled at $129.50. In addition, Fulgent Genetics Inc. saw 102.34% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at FLGT starting from KIM PAUL, who sale 16,958 shares at the price of $51.94 back on Dec 10. After this action, KIM PAUL now owns 174,563 shares of Fulgent Genetics Inc., valued at $880,734 using the latest closing price.
KIM PAUL, the CFO and Treasurer of Fulgent Genetics Inc., sale 10,662 shares at $51.60 during a trade that took place back on Dec 09, which means that KIM PAUL is holding 191,521 shares at $550,189 based on the most recent closing price.
Stock Fundamentals for FLGT
Current profitability levels for the company are sitting at:
- -1.32 for the present operating margin
- +56.63 for the gross margin
The net margin for Fulgent Genetics Inc. stands at -1.26. The total capital return value is set at -0.63, while invested capital returns managed to touch -0.60. Equity return is now at value 43.60, with 36.60 for asset returns.
Based on Fulgent Genetics Inc. (FLGT), the company’s capital structure generated 3.23 points at debt to equity in total, while total debt to capital is 3.13. Total debt to assets is 2.98, with long-term debt to equity ratio resting at 2.73. Finally, the long-term debt to capital ratio is 2.64.
When we switch over and look at the enterprise to sales, we see a ratio of 6.63, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 4.84 and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.96.